Effect of Glucose Insulin Potassium Infusion on Myocardial Injury and Endothelin-1 Levels in Chronic Ischemic Heart Failure;Kronik İskemik Kalp Yetersizliǧinde Glukoz-İnsü lin-Potasyum Infüzyonunun Endotelin-1 Düzeyleri ve Miyokard Hasarma Etkisi

Turk Kardiyoloji Dernegi Arsivi

Volumn 32, Issue 2, 2004, Pages 99-106

  Yazici, Mustafa ^a   Demircan, Sabri ^a   Aksakal, Emre ^a   Soylu, Korhan ^a   Şahin, Mahmut ^a   Saǧkan, Olcay ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Chronic heart failure; Endothelin 1; Glucose insulin potassium infusion; Myocardial injury

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; GLUCOSE; INSULIN; NITRIC ACID DERIVATIVE; POTASSIUM; SPIRONOLACTONE; TROPONIN I;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; SIDE EFFECT;

EID: 1642284126     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mancia G: Sympathetic activation in congestive heart failure. Eur Heart J 1990; 11(supp A): 3-11
2. Tombe PP: Altered contractile function in heart failure. Cardiovasc Res 1998;37:367-80
3. Drexler H: Endothelium as a therapeutic target in heart failure. Circulation 1998;98:2652-5
4. Drexler H: Endothelial dysfunction: clinical implication. Prog Cardiovasc Dis 1997;39:287-324
5. Good JM, Nihoyannopoulos P, Ghatei MA, et al: Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II. Eur Heart J 1994;15:1634-40
6. Kinugawa T, Kato M, Ogino K, et al: Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. J Card Fail 2003;4:318-24
7. Pacher R, Stanek B, Hulsmann M, et al: Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633-41
8. Pousset F, Isnard R, Lechat P, et al: Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997; 18:254-8
9. Persson H, Andreasson K, Kahan T, et al: Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists. Eur J Heart Fail 2002;4:73-82
10. Pool-Wilson PA, Swedberg K, Cleland JG, et al: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:7-13
11. Torre-Amione G, Young JB, Durand JB, et al: Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation 2001;103:973-80
12. Spieker LE, Noll G, Ruschitzka FT, Luscher TF: Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J Am Coll Cardiol 2001;37:1493-505.
13. King LM, Opie LH: Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow, Cardiovasc Res 1998;39:381-92
14. Diaz R, Paolasso EA, Piegas LS, et al: Metabolic modulation of myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation 1998;98:2227-34
15. Lell WA, Nielsen VG, McGriffin DC, et al: Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg 2002;73:1246-52
16. Khoury VK, Haluska B, Prins J, Marwick TH: Effects of glucose-insulin-potassium infusion on chronic ischeamic left ventricular dysfunction. Heart 2003;89:61-5
17. Cottin Y, Lhuillier I, Zeller M, et al: Glucose insulin potassium improves systolic function in patients with chronic ischemic cardiomyopathy. Eur J Heart Fail 2002;4:181-4
18. Parsonage WA, Hetmanski D, Cowley AJ: Beneficial haemodynamic effects of insulin in chronic heart failure. Heart 2001;85:508-13
19. Teicholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-11
20. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R: Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:2226-30
21. Lazar HL: Enhanced preservation of acutely ischemic myocardium and improved clinical outcome using glucose-insulin-potassium (GIK) solutions. Am J Cardiol 1997;80:90A-93A
22. Angelos MG, Murray HN, Gorsline RT, Klawitter PF: Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics. Resuscitation 2002;55:329-36
23. Whitlow PL, Rogers WJ, Smith LG, et al: Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol 1982;49:811-20
24. Bruemmer-Smith S, Avidan MS, Harris B, et al: Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesth 2002;88:489-95
25. Apstein CS, Taegtmeyer H: Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial. Circulation 1997;96:1074-7
26. , Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS: Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocte suspensions. Circ Res 1991;68:466-81
27. Haider W, Eckersberger F, Wolner E: Preventive insulin administration for myocardial protection in cardiac surgery. Anesthesiology 1984;60:422-9
28. Cardillo C, Nambi SS, Kilcoyne CM, et al: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999;100:820-5
29. Tune JD, Mallet RT, Downey F: Insulin improves contractile function during moderate ischemia in canine left ventricle. Am J Physiol 1998;274:H1574-H1581
30. Gupta MP, Lee S, Dhalla NS: Activation of heart sarcoplasmic reticulum Ca2+-stimulated adenosine triphosphate by insulin. J Pharmacol Exp Ther 1989;249:623-30
31. Apstein CS, Gravino FN, Haudenschild CC: Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Circ Res 1983;52:515-26
32. Bersin RM, Wolfe C, Kawasmas M, et al: Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol 1994;23:1617-24
33. Ohnishi N, Iwasaki K, Kusachi S, et al: Low incidance of minor miyocardial damage associated with ballon coronary stenting detected by serum troponin T comparable to that with ballon coronary angioplasty. Jpn Heart J 1998 Mar;39:139-46
34. Colucci WS, Braunwald E. Pathophysiology of heart failure. Braunwald E, Zipes DP, Libby P: Textbook of Cardiovasculer Medicine 6th ed, W.B Saunders Company, Philadelphia 2001;ch 16,page:503-33
35. Missov E, Calzolari C: Elevated cardiac troponin I in some patients with severe congestive heart failure. Circulation 1997;96:2953-8
36. La Vecchia L, Mezzena G, Zanolla L, et al: Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 2000;19:644-52